← All trials
NCT04794842
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2021
- Primary completion
- Mar 31, 2022
- Completion date
- Dec 31, 2022
- First posted
- Mar 12, 2021
- Last posted
- Sep 14, 2021
- Enrollment
- 80
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Our Lady of the Lake Regional Medical CenterLead sponsor
- Our Lady of the Lake Regional Medical CenterReponsible party - principal investigator
- Louisiana State UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.